Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | epidermal growth factor receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | epidermal growth factor receptor | 0.0097 | 0.0457 | 0.0457 |
Brugia malayi | thymidylate synthase | 0.0126 | 0.0797 | 0.0797 |
Chlamydia trachomatis | dihydrofolate reductase | 0.0916 | 1 | 0.5 |
Echinococcus granulosus | thymidylate synthase | 0.0126 | 0.0797 | 0.0797 |
Echinococcus granulosus | dihydrofolate reductase | 0.0916 | 1 | 1 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0594 | 0.6245 | 0.5 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0594 | 0.6245 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.018 | 0.1428 | 0.1428 |
Mycobacterium leprae | DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) | 0.0916 | 1 | 1 |
Echinococcus granulosus | melanoma receptor tyrosine protein kinase | 0.0097 | 0.0457 | 0.0457 |
Echinococcus granulosus | epidermal growth factor receptor | 0.018 | 0.1428 | 0.1428 |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 0.0916 | 1 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0096 | 0.0445 | 0.0445 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.018 | 0.1428 | 0.1428 |
Echinococcus multilocularis | thymidylate synthase | 0.0126 | 0.0797 | 0.0797 |
Brugia malayi | Furin-like cysteine rich region family protein | 0.018 | 0.1428 | 0.1428 |
Onchocerca volvulus | 0.0126 | 0.0797 | 0.5 | |
Schistosoma mansoni | tyrosine kinase | 0.0096 | 0.0445 | 0.0445 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0126 | 0.0797 | 0.0797 |
Echinococcus multilocularis | dihydrofolate reductase | 0.0916 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.006 | 0.0028 | 0.0028 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.0916 | 1 | 1 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0594 | 0.6245 | 1 |
Schistosoma mansoni | dihydrofolate reductase | 0.0916 | 1 | 1 |
Brugia malayi | Dihydrofolate reductase | 0.0916 | 1 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0097 | 0.0457 | 0.0457 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0126 | 0.0797 | 0.0772 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.018 | 0.1428 | 0.1428 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0594 | 0.6245 | 0.5 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0097 | 0.0457 | 0.0457 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0594 | 0.6245 | 0.5 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0594 | 0.6245 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0097 | 0.0457 | 0.0457 |
Mycobacterium ulcerans | dihydrofolate reductase DfrA | 0.0916 | 1 | 1 |
Loa Loa (eye worm) | thymidylate synthase | 0.0126 | 0.0797 | 0.0797 |
Schistosoma mansoni | tyrosine kinase | 0.0096 | 0.0445 | 0.0445 |
Trichomonas vaginalis | conserved hypothetical protein | 0.006 | 0.0028 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 7.92 | Inhibition of EGFR (unknown origin) | ChEMBL. | 18271520 |
IC50 (binding) | = 12 nM | Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles | ChEMBL. | 8568816 |
IC50 (binding) | = 12 nM | Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles | ChEMBL. | 8568816 |
Log IC50 (binding) | = 7.92 | Inhibition of EGFR (unknown origin) | ChEMBL. | 18271520 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.